146(top 1%)
papers
9.1K(top 1%)
citations
47(top 1%)
h-index
94(top 1%)
g-index
150
all documents
9.7K
doc citations
1.4K
citing journals

Top Articles

#TitleJournalYearCitations
1Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical ProstatectomyJournal of Nuclear Medicine2015907
2Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate CancerJournal of Urology2016659
3Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up studyEuropean Journal of Nuclear Medicine and Molecular Imaging2003510
4Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate CancerEuropean Urology2016456
568Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human StudiesJournal of Nuclear Medicine2015432
6Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapyInternational Journal of Radiation Oncology Biology Physics2005351
7Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imagingJournal of Nuclear Medicine1999331
8Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer diseaseNeurology2009235
968Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy PlanningJournal of Nuclear Medicine2018226
10Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage LymphadenectomyJournal of Nuclear Medicine2016213
1199mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate CancerEuropean Urology2019195
12Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate CancerEuropean Urology2015192
13Preclinical Evaluation and First Patient Application of99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate CancerJournal of Nuclear Medicine2017170
14PSMA Ligands for PET Imaging of Prostate CancerJournal of Nuclear Medicine2017165
15Initial Characterization of an 18F-Labeled Myocardial Perfusion TracerJournal of Nuclear Medicine2008145
16Radiation Dosimetry for177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor LesionsJournal of Nuclear Medicine2017144
1718F-Labeled Galacto and PEGylated RGD Dimers for PET Imaging of αvβ3 Integrin ExpressionMolecular Imaging and Biology2010131
18Assessment of Local Brain ActivationAdvances in Experimental Medicine and Biology1997127
19Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptorsJournal of Experimental Medicine2018121
20Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective studyLancet Oncology, The2021120
2168Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective StudyJournal of Nuclear Medicine2017111
2268Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET ImagingJournal of Nuclear Medicine2018106
23Self-gated MRI motion modeling for respiratory motion compensation in integrated PET/MRIMedical Image Analysis2015103
24Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging2015100
2511C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapyInternational Journal of Radiation Oncology Biology Physics200697
26Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian InferenceIEEE Transactions on Medical Imaging201996
27Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PETJournal of Nuclear Medicine201794
28Value of 111In‐prostate‐specific membrane antigen (PSMA)‐radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow‐upBJU International201788
29Effect of 11C-Methionine-Positron Emission Tomography on Gross Tumor Volume Delineation in Stereotactic Radiotherapy of Skull Base MeningiomasInternational Journal of Radiation Oncology Biology Physics200885
30Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PETEuropean Journal of Nuclear Medicine and Molecular Imaging200484
31Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate CancerJournal of Nuclear Medicine201976
32Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical CystectomyEuropean Urology201275
33Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cellsEuropean Journal of Nuclear Medicine and Molecular Imaging200674
34Resting-State Networks as Simultaneously Measured with Functional MRI and PETJournal of Nuclear Medicine201771
35Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junctionJournal of Nuclear Medicine200571
3618F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyJournal of Nuclear Medicine202067
37Detection Efficacy of Hybrid 68Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix CriteriaJournal of Nuclear Medicine201766
38Technologies for image-guided surgery for managing lymphatic metastases in prostate cancerNature Reviews Urology201962
39PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0European Journal of Nuclear Medicine and Molecular Imaging202362
40A New 18F-Labeled Myocardial PET Tracer: Myocardial Uptake After Permanent and Transient Coronary Occlusion in RatsJournal of Nuclear Medicine200860
41Evaluation of a Novel 18 F-Labeled Positron-Emission Tomography Perfusion Tracer for the Assessment of Myocardial Infarct Size in RatsCirculation: Cardiovascular Imaging200958
42Analgesia by electrostimulation of the trigeminal ganglion in patients with trigeminopathic pain: a PET activation studyPain200356
43Magnetic resonance imaging of myocardial injury and ventricular torsion after marathon runningClinical Science201155
44Evaluation of Feasibility and Image Quality of 68Ga-DOTATOC Positron Emission Tomography/Magnetic Resonance in Comparison With Positron Emission Tomography/Computed Tomography in Patients With Neuroendocrine TumorsInvestigative Radiology201355
45One-Stop-Shop Whole-Body 68Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate CancerJournal of Nuclear Medicine201855
46The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA PeptidesJournal of Nuclear Medicine201854
47Disruption of the PRKCD–FBXO25–HAX-1 axis attenuates the apoptotic response and drives lymphomagenesisNature Medicine201450
48Targets for Therapy of Bladder CancerSeminars in Nuclear Medicine202049
49Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activityContraception199748
50Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0European Journal of Nuclear Medicine and Molecular Imaging202248